Schwarz ER, Phan A, Willix Jr RD. Andropause and the development of cardiovascular disease presentation -more than an epi-phenomenon. J Geriatr Cardiol 2011; 8: 35-43. DOI: 10.3724/SP.J.1263.2011.00035
Saad F, Aversa A, Isidori AM, Gooren LJ. Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review. Curr Diab Rev 2012; 8: 131-143. DOI: 10.2174/157339912799424573
Brawer MK. Testosterone replacement in men with andropause: an overview. Rev Urol 2004; 6: S9-S15. PMID: 16985914;PMCID: PMC1472881
Saalu LC, Osinubi AA. Andropause (male menopause): valid concepts, fables and controversies. J Basic Med Sci 2013; 1: 33-37. Corpus ID: 78722056
Kim SH. Testosterone replacement therapy and bone mineral density in men with hypogonadism. En-docrinol Metab 2014; 29: 30-32. DOI: 10.3803/EnM.2014.29.1.30
Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, et al. Validation of a screening ques-tionnaire for androgen deficiency in aging males. Metabolism 2000; 49: 1239–1242. DOI: 10.1053/meta.2000.8625.
Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ. American Association of Clini-cal Endocrinologists. Hypogonadism Guidelines, American association of clinical endocrinologists medical guidelines for clinical practice for the evalua-tion and treatment of hypogonadism in adult male pa-tients - 2002 update. Endocr Pract 2002; 8: 439-456. PMID: 15260010
Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 57: M76–M99. DOI:10.1093/gerona/57.2.M76
Wespes E, Schulman CC. Male andropause: myth, real-ity, and treatment. Int J Impot Res 2002; 14: S93–S98. DOI:10.1038/sj.ijir.3900798.
Verma P, Mahajan KK, Mittal S. Andropause - a debat-able physiological process. JK Science J Med Educ Res 2006; 8: 68-72.
Tostes RC, Carneiro FS, Carvalho MHC, Reckelhoff JF. Reactive oxygen species: players in the cardiovas-cular effects of testosterone. Am J Physiol Regul In-tegr Comp Physiol 2016; 310: R1–R14. DOI:10.1152/ajpregu.00392.2014
Motamedi S, Karimi I, Jafari F. The interrelationship of metabolic syndrome and neurodegenerative disease: fo-cus on brain-derived neurotrophic factor. Metab Brain Dis 2017. DOI:10.1007/s11011-017-9997-0
Villareal DT, Apovian CM, Kushner RF, Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J ClinNutr 2005; 82: 923–934. DOI: 10.1093/ajcn/82.5.923
Sofimajidpour H, Teimoori T, Gharibi F. The effect of testosterone on men with andropause. Iran Red Crescent Med J 2015; 17: e19406. DOI: 10.5812/ircmj.19406
Jang H, Bae WJ, Kim SJ, Yuk SM, Han DS, Ha US, et al. The effect of anthocyanin on the prostate in an andropause animal model: rapid prostatic cell death by apoptosis is partially prevented by anthocyanin sup-plementation. World J Mens Health 2013; 31: 239-
DOI: 10.5534/wjmh.2013.31.3.239
Khosla S, Atkinson EJ, Dunstan CR, O’Fallon WM. Ef-fect of estrogen versus testosterone on circulating osteo-protegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab 2002; 87:1550-1554
Graves DT, Oates T Garlet GP. Review of osteoimmu-nology and the host response in endodontic and perio-dontal lesions. J Oral Microbiol 2011; 3: DOI: 10.3402/jom.v3i0.5304
Ismail M, Al-Taher AY. Effect of propetamphos on the male rats reproductive system. Environ Toxicol Pharma-col 2011; 31: 333-338. DOI: 10.1016/j.etap.2011.01.001
Dawson J, Walters M. Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovas-cular disease? Br J Clin Pharmacol 2006; 62: 633-644. DOI: 10.1111/j.1365-2125.2006.02785.x
Khany A, Karimi I, Alimoradian D, Zavareh S. Distri-bution of xanthine oxidase in selected tissues of a mouse model of menopause. J Chem Health Res 2016; 6: 225-235.
Feig DI, Kang DH, Richard J. Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811–1821. DOI: 10.1056/NEJMra0800885
Friedewald WT, Ley RI, Fradrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentri-fuge. Clin Chem 1972; 18: 499–502. PMID: 4337382
Lee R, Niemann D. Nutritional assessment. Mosby, Missouri. 1996.
Kinosian B, Glick H, Garland G. Cholesterol and coro-nary heart disease: predicting risks by levels and ratios. Ann Intern Med 1994; 121: 641–664. PMID: 8528755
Naseri D, Asasi K, Karimi I. Similar developmental fluctuations of hepato-renal xanthine oxidoreductase gene expression and xanthine oxidase activity in layer and broiler chicken embryos. Br Poult Sci 2017; 58 (2):
- 150. DOI: 10.1080/00071668.2016.1268250
Bradford MM. Rapid and sensitive method for the quan-titation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254. DOI: 10.1006/abio.1976.9999
Isayama RN, Oishi J, Cagnon VHA, Campos GER. Ef-fect of testosterone on skeletal muscle of young and old male rats. Braz J Morphol Sci 2006; 23: 247-253.
Carnegie C. Diagnosis of hypogonadism: clinical as-sessments and laboratory tests. Rev Uro 2004; 6(Suppl 6): S3-S8. PMID: 16985909
Fahed AC, Gholmieh JM, Azar ST. Connecting the lines between hypogonadism and atherosclerosis. Int J Endo-crinol 2012; 793953. DOI:10.1155/2012/793953
Sheehy CM, Perry PA, Cromwell SL. Dehydration: biological considerations, age-related changes, and risk factors in older adults. Biol Res Nurs 1999; 1(1):30-37. DOI: 10.1177/109980049900100105
Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, et al. Allopurinol improves myo-cardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 2001; 104: 2407-2411. DOI:10.1161/hc4501.098928
Higgins P, Dawson J, Lees KR, McArthur K, Quinn TJ, Walters MR. Xanthine oxidase inhibition for the treat-ment of cardiovascular disease: a systematic review and meta-analysis. Cardiovasc Ther 2012; 30:217–226. DOI:10.1111/j.1755-5922.2011.00277.x
Lin C-Y, Lin M-T, Cheng R-T, Chen S-H. Testosterone depletion by castration may protect mice from heat-in-duced multiple organ damage and lethality. J Biomed Biotech 2010; 485306. DOI:10.1155/2010/485306
Powers SK, Kavazis AN, De Ruisseau KC. Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol 2005; 288: R337-R344. DOI: 10.1152/ajpregu.00469.2004
Bravard A, Bonnard C, Durand A, Chauvin MA, Favier R, Vidal H, et al. Inhibition of xanthine oxidase reduces hyperglycemia-induced oxidative stress and improves mitochondrial alterations in skeletal muscle of diabetic mice. Am J Physiol Endocrinol Metab 2011; 300: E581-E591. DOI: 10.1152/ajpendo.00455.2010
Kumagai A, Kodama H, Kumagai J, Fukuda J, Kawa-mura K, Tanikawa H, et al. Xanthine oxidase inhibitors suppress testicular germ cell apoptosis induced by ex-perimental cryptorchidism. Mol Human Reprod 2002; 8(1): 118–123. DOI:10.1093/molehr/8.2.118